Showing 341 - 360 results of 107,668 for search '(( i point decrease ) OR ( 5 ((((step decrease) OR (teer decrease))) OR (a decrease)) ))', query time: 1.77s Refine Results
  1. 341
  2. 342

    Fig 5 - by Melissa K. Peckins (12042132)

    Published 2022
    Subjects:
  3. 343

    Inclusion of SRRM4-regulated exons is decreased in tumors and cancer cell lines. by Sarah A. Head (6066398)

    Published 2021
    “…(B) SRRM4 target exons with respect to their average PSI in normal tissues. Red points are exons with PSI decreasing by at least 5% in at least 1 tumor type. …”
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350
  11. 351
  12. 352
  13. 353
  14. 354

    GRIP1<sup>-/-</sup> platelets do not have decreased velocity in ionophore-stimulated blood vessels. by Kristina L. Modjeski (3123072)

    Published 2016
    “…Blood was then pumped over a mouse vWF-coated MatTek chamber. Platelet adhesion was determined at multiple time points (N = 4–6 per time point, P < 0.1 at 15 sec).…”
  15. 355

    <i>In vivo</i> treatment with entinostat decreases Foxp3 expression in Tregs and inhibits Tregs function. by Li Shen (110858)

    Published 2012
    “…Cells were harvested from spleens and lymph nodes. A, <i>In vivo</i> entinostat treatment decreased the expression level of Foxp3 in CD4<sup>+</sup>Foxp3<sup>+</sup> (Treg) cells. …”
  16. 356
  17. 357

    Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis-5 by Mrigank Srivastava (94935)

    Published 2011
    “…The data are shown as mean ± SD of at least n = 10 mice per group and time point. * indicates significant increase (< 0.05) compared to cathepsin K transgenic mice. + indicates significant decrease (< 0.05) compared to the respective mock-treated mice.…”
  18. 358
  19. 359
  20. 360